Impact of coenzyme Q10 on inflammatory biomarkers and its role in future therapeutic strategies.

Behnaz Abiri, Mohammadreza Vafa

Journal: Clinical nutrition ESPEN 2021;43():25-30

PMID: 34024523

Full Text on Elsevier Science View on PubMed

Abstract

Coenzyme Q (CoQ) is an important component of the mitochondrial electron transport chain. The finding that multiple chronic diseases show lower levels of CoQ10 has led to the possibility that CoQ10 supplementation could be an effective approach to ameliorate or prevent disease progression. In this review, we discuss the state of the art regarding the role of CoQ10 in health and disease and describe the latest clinical studies which have tested the effects of CoQ10 supplementation in inflammatory diseases. The results of these studies indicate that individuals suffering from inflammation-related diseases show improvement under the CoQ10 supplementation protocol. However, these results have been inconsistent, leading to the need for additional studies at the preclinical and clinical levels, involving a greater number of subjects and different treatment regimes.

Address: Nutritional Sciences, Department of Nutrition, Faculty of Paramedicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.; Nutritional Sciences, Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran. Electronic address: [email protected].

DOI: 10.1016/j.clnesp.2021.04.005

Link outs

Free resources

Other Literature Sources:

https://scite.ai/reports/34024523

Subscription / membership required

Full Text Sources:

MeSH Terms: Biomarkers, Humans, Ubiquinone